Client News

Medigene AG Presents UniTope and TraCR a Universal Detection System for 3S Recombinant TCRs at ASGCT 2024

Formycon Published Results of Analytical Similarity Study of Biosimilar Candidate FYB206 and Keytruda®1 in Peer-Reviewed Journal Drugs in R&D

invIOs Raises €8.2 Million in a Series A to Finance Pipeline Progress in Immuno-Oncology

Affluent Medical Announces Participation in Upcoming Scientific Events

Nyxoah Raises $27 Million through its At-the-Market Offering

Pentixapharm Holding AG Completes IPO in the Prime Standard of the Frankfurt Stock Exchange

CARBIOS Announces Half-Year 2024 Financial results and Presents its Industrial and Commercial Progress

Pentixapharm Holding AG: Placement Price Set at EUR 5.10 per Share, All 3.9 Million Offer Shares Placed

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025

Formycon and Fresenius Kabi Receive FDA Approval for FYB202/ OtulfiTM (ustekinumab-aauz)